Article Per Year (5 Year)
p-Index From 2019 - 2024
0.408
P-Index
This Author published in this journals
All Journal Care : Jurnal Ilmiah Ilmu Kesehatan JOURNAL OF COMMUNITY MEDICINE AND PUBLIC HEALTH RESEARCH
Rifdah, Salsabila Nabilah
Unknown Affiliation
Health Professions Medicine & Pharmacology Nursing Public Health

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search

 1 
KARAKTERISTIK PENDERITA OMSK TIPE AMAN DENGAN RINITIS ALERGI DI IRJ RSUD DR. SOETOMO SURABAYA PERIODE JULI — DESEMBER 2017 rifdah, salsabila nabilah; artono, artono; rahardjo, paulus
Care : Jurnal Ilmiah Ilmu Kesehatan Vol 9, No 1 (2021): EDITION MARCH 2021
Publisher : Universitas Tribhuwana Tunggadewi

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.33366/jc.v9i1.1381

Abstract

Chronic suppurative otitis media (CSOM) is a chronic inflammatory process of the middle ear mucosa and mastoid cavity accompanied by tympanic membrane perforation and a history of discharge from the ear canal for more than two months, whether continuous or intermittent. The presence of allergies is thought to play an important role in the occurrence of safe type CSOM. Until now there have been no studies on the characteristics of safe type CSOM patients with allergic rhinitis at the IRJ Hospital Dr. Soetomo Surabaya in 2017. Based on this, it is necessary to conduct research to find out information on the characteristics of patients with safe type CSOM with allergic rhinitis at the IRJ Hospital Dr. Soetomo Surabaya. This study was a retrospective descriptive observational study on secondary data in the form of medical records in patients with safe type CSOM with allergic rhinitis who were treated at the RSUD Dr. Soetomo Surabaya. The results showed that the highest sex distribution was women (75%), the most age group was the age range of 21-30 years (30.56%), the most regional origin was Surabaya (58.33%), the highest employment status was not working (50%), most patients had a history of allergies (86.11%), the most family history of allergic patients was eczema (41.67%), and most allergens were house dust mites (77.77%).
COMPARISON OF MORTALITY BETWEEN THE COMBINATION OF STANDARD THERAPY AND CONVALESCENT PLASMA THERAPY AND STANDARD THERAPY ONLY IN COVID-19 PATIENTS : SYSTEMATIC REVIEW AND META-ANALYSIS Klarin, Felicia; Vita, Angelica Diana; Siahaan, Cynthia Elvira Sari; Rifdah, Salsabila Nabilah; Putri, Ayu Rahmanita; Kusuma, Indriasti Putri; Prayitno, Subur
Journal of Community Medicine and Public Health Research Vol. 2 No. 2 (2021): Journal of Community Medicine and Public Health Research
Publisher : Universitas Airlangga

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (431.579 KB) | DOI: 10.20473/jcmphr.v2i2.27432

Abstract

Coronavirus Disease-19 (COVID-19) is an infectious disease caused by a newly discovered type of coronavirus. Comprehensive management for COVID-19 patients includes infection control, hemodynamic stability maintenance, oxygenation monitoring, ventilation, and pharmacotherapy administration. Convalescent plasma is one of the COVID-19 therapy choices, proven to provide relief for Ebola, SARS, and MERS patients. Therefore, the authors believed in searching data on whether convalescent plasma therapy also improves COVID-19 patients, specifically in terms of mortality. This study aims to compare the comparison in mortality between standard therapy and convalescent plasma therapy with standard therapy only in COVID-19 patients. This study used a systematic review and meta-analysis method according to the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines. This study used ten studies that met the inclusion criteria to evaluate the comparison in mortality between the combination therapy with standard therapy only in COVID-19 patients. There was a significant difference in mortality between the combination of standard therapy and convalescent plasma therapy with standard therapy only in COVID-19 patients, and mortality in the combination therapy groups being lower than standard therapy only.
Co-Authors Artono Artono, Artono Klarin, Felicia Kusuma, Indriasti Putri Paulus Rahardjo, Paulus Prayitno, Subur Putri, Ayu Rahmanita Siahaan, Cynthia Elvira Sari Vita, Angelica Diana